Skip to main content
Equibles

Jefferies Financial Group Inc.

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 96223 NEW YORK, NY
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$7,477,901
-$856,620 QoQ
Shares Held
118,810
0.0% QoQ
Ownership
0.271%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#49
of 256 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names. TARS ranks #17 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PTCT
Ptc Therapeutics, Inc.
 1,357,042 $110,693,915
2 URGN
UroGen Pharma Ltd.
 2,199,652 $80,947,193
3 IMTX
Immatics N.V.
 6,506,802 $65,913,904
4 TNGX
Tango Therapeutics, Inc.
 2,010,534 $62,849,292
5 CGON
CG Oncology, Inc.
 769,947 $54,704,734
6 ARGX
Argenx SE
 45,068 $41,812,738
7 RARE
Ultragenyx Pharmaceutical Inc.
 929,626 $31,040,212
8 BMRN
Biomarin Pharmaceutical Inc
 466,258 $26,679,282

All Filings in TARS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,477,901 118,810
2026-03-31 $8,334,521 118,810
2025-12-31 $9,728,162 118,810
2025-09-30 $6,719,690 113,069
2025-06-30 $6,602,967 162,996
2025-03-31 $4,048,366 78,808
2024-12-31 $23,297,370 420,758
2024-09-30 $13,838,730 420,758
2024-06-30 $11,436,202 420,758
2024-03-31 $9,842,053 270,758
2023-12-31 $7,710,349 380,758
2023-09-30 $5,877,569 330,758
2023-06-30 $6,428,547 355,758
2023-03-31 $5,603,178 445,758
2022-12-31 $6,534,812 445,758